You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


ConserV Bio partners with eTheRNA on mRNA vaccine development

London, UK-based ConserV Bioscience has teamed up with eTheRNA immunotherapies to develop mRNA-based vaccines for infectious diseases.